A Pipeline that is Defined by Patients Needs
At Processa Pharmaceuticals, we focus on developing drugs that target life-threatening and life-compromising chronic diseases. These drugs are ready, or near ready, for clinical development. We acquire therapies that already have demonstrated some clinical data to support the targeted treatment: studies of the drug itself, an analog of the drug, or a drug with similar pharmacological targets. We then work with the FDA to define a complete development program and out-license the drug before or after the pivotal study.